$70.79

-0.35 (-0.49%)

Weekly Expected Move ±4.8%

$64 $68 $71 $74 $78

NYSE · Financial Services · Asset Management · Tech Score Neutral · Power 44 · $3.6B mcap · 28M float · 1.09% daily turnover · Short 62% of daily vol

Credit Risk of going bust: not rated, financial company (lending is its business) Bonds: none of note held by US funds details ▾

Not rated: lending and leverage are a financial company's business, which the model misreads.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE

45.0 / 100

NoneWeakNarrowWide

Primary source: Efficient Scale · ROIC: 138.0% · 5Y Avg: 13.6%

Cost Advantage

Intangibles

Switching Cost

Network Effect

Scale ★

The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CNS shows a Weak competitive edge (45.0/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Efficient Scale. ROIC of 138.0% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

Low

$88

Avg Target

$88

High

Based on 5 analyst ratings (12 mo)

Analyst Recommendations

Strong Buy: 0Buy: 4Hold: 4Sell: 5Strong Sell: 0

Rating Summary

ConsensusSell

Avg Target$88.00

Analysts1

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2026-08-10	Evercore ISI	—	$84	$88	+4	+7.4%	$81.93
2026-07-10	Evercore ISI	John Dunn	$82	$84	+2	+8.1%	$77.70
2026-06-08	Evercore ISI	John Dunn	$76	$82	+6	+10.4%	$74.30
2026-04-20	Evercore ISI	John Dunn	$75	$76	+1	+11.8%	$68.00
2026-04-10	Evercore ISI	John Dunn	$73	$75	+2	+18.0%	$63.56
2024-10-16	UBS	Brennan Hawken	Initiated	$102	—	+0.8%	$101.17
2024-04-19	Evercore ISI	John Dunn	Initiated	$73	—	+10.4%	$66.11

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

Oct 27, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CNS receives an overall rating of C. Strongest factors: ROE (5/5). Areas of concern: DCF (2/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).

Rating Change History

Date	From	To
2026-10-27	D+	C
2026-10-26	C-	D+
2026-10-16	A-	C-
2026-10-12	B+	A-
2026-08-05	B	B+
2026-07-31	C-	B
2026-07-23	B+	C-
2026-07-20	A-	B+
2026-07-15	B+	A-
2026-07-14	A-	B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 55 Grade B

Profitability

Balance Sheet

Earnings Quality

Growth

Value

Momentum

Safety

100

Cash Flow

The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CNS scores highest in Safety (100/100) and lowest in Earnings Quality (28/100). A grade of B indicates above-average fundamentals with room for improvement in select areas.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

12.61

Safe Zone

Piotroski F-Score

5/9

✓ ✓ ✗ ✗ ✓ ✗ ✗ ✓ ✓

Beneish M-Score

-1.27

Possible Manipulator

Ohlson O-Score

-9.27

Bankruptcy prob: 0.0%

Low Risk

Credit Rating

Score: 88.5/100

Trend: Improving

Earnings Quality

25/100

OCF/NI: 0.25x

Accruals: 14.9%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CNS scores 12.61, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CNS scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CNS's score of -1.27 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CNS's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CNS receives an estimated rating of AA (score: 88.5/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). CNS's score of 25/100 is low — reported earnings may not be fully supported by cash flows.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

21.58x

PEG

9.90x

P/S

5.93x

P/B

6.18x

P/FCF

97.40x

P/OCF

90.90x

EV/EBITDA

14.13x

EV/Revenue

5.43x

EV/EBIT

14.78x

EV/FCF

85.19x

Earnings Yield

4.43%

FCF Yield

1.03%

Shareholder Yield

4.16%

Graham Number

$28.71

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 21.6x earnings, CNS commands a growth premium. Graham's intrinsic value formula yields $28.71 per share, 147% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

0.742

NI / EBT

Interest Burden

1.009

EBT / EBIT

EBIT Margin

0.368

EBIT / Rev

Asset Turnover

0.721

Rev / Assets

Equity Multiplier

1.494

Assets / Equity

ROE

29.6%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CNS's ROE of 29.6% is driven by Asset Turnover (0.721), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate

6.86%

Fair P/E

22.22x

Intrinsic Value

$71.99

Price/Value

1.02x

Margin of Safety

-1.56%

Premium

1.56%

Assessment

Neutral

Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with CNS's realized 6.9% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. CNS trades at a 2% premium to its adjusted intrinsic value of $71.99, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 22.2x compares to the current market P/E of 21.6x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$70.77

Median 1Y

$71.12

5th Pctile

$38.20

95th Pctile

$132.36

Ann. Volatility

36.9%

Analyst Target

$88.00

25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

Executive	Salary	Stock	Total
Joseph Harvey, CEO	$600,000	$4,719,995	$6,991,951
Jon Cheigh, CIO sident and CIO	$500,000	$2,479,948	$6,731,339
Daniel Charles, Head er Head of Global Distribution	$218,750	$7,818,495	$4,865,078
Daniel Noonan, Head of Global Distribution	$350,000	$648,955	$2,347,583
Adam Derechin, COO	$375,000	$679,984	$1,868,145
Michael Donohue, Interim CFO	$350,000	$578,697	$1,594,040
Raja Dakkuri, Former CFO	$329,766	$727,858	$1,114,678

CEO Pay Ratio

42:1

CEO-to-Employee Pay Ratio

CEO Total Comp: $6,991,951

Avg Employee Cost (SGA/emp): $168,005

Employees: 424

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

424

+3.2% YoY

Revenue / Employee

$1,339,156

Rev: $567,802,000

Profit / Employee

$361,361

NI: $153,217,000

SGA / Employee

$168,005

Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Q3'26	Current
ROE	98.5%	92.0%	81.5%	70.0%	57.7%	55.5%	44.9%	38.6%	35.9%	35.7%	31.3%	31.5%	33.9%	35.4%	32.7%	31.5%	28.5%	29.1%	30.1%	29.6%	29.63%
ROA	50.3%	44.6%	42.8%	41.6%	29.3%	27.2%	24.0%	22.3%	18.3%	19.6%	18.1%	19.3%	19.5%	20.7%	21.1%	21.5%	17.8%	18.4%	20.4%	19.8%	19.83%
ROIC	2.9%	1.1%	2.0%	1.7%	76.7%	56.0%	53.8%	47.9%	48.7%	35.1%	34.9%	37.1%	39.2%	32.3%	33.1%	36.8%	24.6%	21.1%	1.4%	1.4%	1.38%
ROCE	57.2%	52.9%	48.2%	52.8%	34.1%	36.2%	32.3%	28.0%	24.3%	26.6%	22.0%	25.1%	24.1%	24.4%	27.7%	27.9%	21.2%	23.3%	25.8%	26.6%	26.63%
Gross Margin	59.9%	42.5%	51.1%	51.3%	50.8%	50.0%	49.8%	46.2%	49.3%	48.4%	47.7%	48.7%	50.1%	50.1%	49.2%	48.1%	82.1%	85.3%	88.3%	82.5%	82.46%
Operating Margin	50.4%	33.1%	41.4%	40.9%	36.6%	35.6%	32.9%	33.0%	30.7%	31.8%	30.3%	32.4%	34.1%	32.3%	30.4%	34.5%	28.0%	34.9%	40.1%	31.9%	31.87%
Net Margin	40.4%	27.3%	35.2%	31.8%	25.4%	28.0%	25.6%	26.0%	24.2%	26.9%	25.1%	28.6%	31.7%	28.4%	25.9%	29.4%	24.3%	28.9%	29.6%	27.1%	27.06%
EBITDA Margin	53.4%	38.0%	43.4%	43.8%	42.5%	42.3%	39.8%	36.7%	38.5%	37.0%	36.6%	38.3%	39.5%	38.2%	36.8%	36.5%	29.8%	40.8%	44.7%	37.6%	37.57%
FCF Margin	41.1%	20.3%	16.4%	11.9%	10.1%	26.8%	24.4%	24.7%	23.1%	27.1%	24.8%	19.3%	15.8%	-4.6%	-21.6%	-16.5%	-12.6%	-2.2%	20.6%	6.4%	6.38%
OCF Margin	41.6%	20.8%	16.9%	12.6%	10.8%	28.3%	28.8%	34.2%	34.6%	38.5%	33.9%	23.4%	18.0%	-3.1%	-20.5%	-15.2%	-11.5%	-1.4%	21.2%	6.8%	6.83%
ROE 3Y Avg	snapshot only																				28.68%
ROE 5Y Avg	snapshot only																				37.26%
ROA 3Y Avg	snapshot only																				19.27%
ROIC Economic	snapshot only																				21.65%
Cash ROA	snapshot only																				4.65%
Cash ROIC	snapshot only																				37.57%
CROIC	snapshot only																				35.06%
NOPAT Margin	snapshot only																				25.10%
Pretax Margin	snapshot only																				37.08%
R&D / Revenue	snapshot only																				0.00%
SGA / Revenue	snapshot only																				3.13%
SBC / Revenue	snapshot only																				11.11%

Valuation

Metric	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Q3'26	Current
P/E Ratio	18.98	18.30	13.27	13.64	16.85	17.55	18.35	21.97	27.44	28.43	27.56	35.11	30.55	25.62	23.50	20.43	21.16	20.71	23.46	22.57	21.582
P/S Ratio	6.86	6.11	4.53	4.61	5.06	5.33	5.11	5.77	7.12	7.30	7.03	9.21	8.61	7.31	6.74	5.90	5.71	5.62	6.59	6.21	5.934
P/B Ratio	15.72	14.66	9.63	8.77	8.54	8.56	7.49	7.89	9.29	9.58	7.60	9.67	9.03	7.92	7.21	6.09	5.77	5.73	6.70	6.46	6.176
P/FCF	16.70	30.05	27.66	38.56	50.17	19.88	20.93	23.34	30.80	26.89	28.37	47.67	54.35	-157.63	-31.12	-35.65	-45.35	-251.70	32.02	97.40	97.401
P/OCF	16.52	29.35	26.76	36.64	46.74	18.83	17.73	16.88	20.59	18.94	20.77	39.43	47.80	—	—	—	—	—	31.07	90.90	90.902
EV/EBITDA	13.74	13.12	9.28	9.53	11.58	12.12	11.70	13.82	17.46	19.01	18.24	23.73	21.89	18.82	17.23	14.89	16.14	16.01	15.16	14.13	14.126
EV/Revenue	6.55	6.01	4.22	4.27	4.85	5.22	4.93	5.58	6.87	7.22	6.78	8.92	8.30	7.18	6.58	5.62	5.70	5.76	5.79	5.43	5.432
EV/EBIT	14.58	13.91	9.74	10.03	12.32	12.99	12.85	15.33	19.48	20.98	19.90	25.54	23.17	19.89	18.17	15.72	17.08	16.89	15.89	14.78	14.776
EV/FCF	15.94	29.54	25.80	35.72	48.02	19.48	20.22	22.56	29.71	26.62	27.36	46.14	52.36	-154.80	-30.40	-34.00	-45.25	-258.19	28.15	85.19	85.186
Earnings Yield	5.3%	5.5%	7.5%	7.3%	5.9%	5.7%	5.4%	4.6%	3.6%	3.5%	3.6%	2.8%	3.3%	3.9%	4.3%	4.9%	4.7%	4.8%	4.3%	4.4%	4.43%
FCF Yield	6.0%	3.3%	3.6%	2.6%	2.0%	5.0%	4.8%	4.3%	3.2%	3.7%	3.5%	2.1%	1.8%	-0.6%	-3.2%	-2.8%	-2.2%	-0.4%	3.1%	1.0%	1.03%
PEG Ratio	snapshot only																				9.897
Price/Tangible Book	snapshot only																				6.689
EV/OCF	snapshot only																				79.502
EV/Gross Profit	snapshot only																				6.415
Acquirers Multiple	snapshot only																				16.009
Shareholder Yield	snapshot only																				4.16%
Graham Number	snapshot only																				$28.71

Leverage & Solvency

Metric	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Q3'26	Current
Current Ratio	8.77	2.86	12.29	13.90	19.49	12.47	27.05	14.26	21.93	7.36	32.64	33.58	25.39	15.27	24.33	5.04	14.76	9.86	2.66	2.66	2.662
Quick Ratio	8.77	2.86	12.29	13.90	19.49	12.47	27.05	14.26	21.93	7.36	32.64	33.58	25.39	15.27	24.33	5.04	14.76	9.86	2.66	2.66	2.662
Debt/Equity	0.10	0.08	0.06	0.05	0.41	0.41	0.33	0.36	0.37	0.37	0.31	0.29	0.28	0.28	0.27	0.25	0.25	0.24	0.23	0.23	0.228
Net Debt/Equity	-0.72	-0.25	-0.65	-0.65	-0.37	-0.17	-0.26	-0.26	-0.33	-0.10	-0.27	-0.31	-0.33	-0.14	-0.17	-0.28	-0.01	0.15	-0.81	-0.81	-0.811
Debt/Assets	0.05	0.04	0.03	0.03	0.21	0.22	0.18	0.20	0.19	0.21	0.18	0.19	0.17	0.17	0.19	0.17	0.15	0.16	0.15	0.15	0.149
Debt/EBITDA	0.09	0.08	0.07	0.06	0.58	0.59	0.53	0.66	0.72	0.75	0.76	0.73	0.69	0.67	0.66	0.65	0.69	0.66	0.59	0.57	0.570
Net Debt/EBITDA	-0.66	-0.23	-0.67	-0.76	-0.52	-0.25	-0.41	-0.48	-0.64	-0.19	-0.67	-0.78	-0.83	-0.34	-0.41	-0.72	-0.04	0.40	-2.09	-2.03	-2.026
Interest Coverage	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Equity Multiplier	1.93	2.28	2.00	1.60	1.99	1.85	1.77	1.84	1.93	1.80	1.69	1.48	1.59	1.64	1.42	1.46	1.62	1.52	1.53	1.53	1.529
Cash Ratio	snapshot only																				11.346
Cash to Debt	snapshot only																				4.555
FCF to Debt	snapshot only																				0.291
Defensive Interval	snapshot only																				816.9 days

Efficiency & Turnover

Metric	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Q3'26	Current
Asset Turnover	1.39	1.34	1.26	1.23	0.98	0.90	0.86	0.85	0.71	0.76	0.71	0.74	0.69	0.73	0.74	0.74	0.66	0.68	0.73	0.72	0.721
Inventory Turnover	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Receivables Turnover	7.60	7.59	7.97	7.16	7.55	6.52	7.46	6.73	7.34	6.55	7.79	6.92	7.49	7.13	8.19	7.74	7.37	6.86	7.66	8.08	8.079
Payables Turnover	30.26	32.15	26.83	27.90	31.37	27.26	24.98	26.76	27.40	29.63	29.62	30.12	29.54	35.12	32.83	33.84	28.21	24.00	33.63	21.62	21.620
DSO	48	48	46	51	48	56	49	54	50	56	47	53	49	51	45	47	50	53	48	45	45.2 days
DIO	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.0 days
DPO	12	11	14	13	12	13	15	14	13	12	12	12	12	10	11	11	13	15	11	17	16.9 days
Cash Conversion Cycle	36	37	32	38	37	43	34	41	36	43	35	41	36	41	33	36	37	38	37	28	28.3 days
Fixed Asset Turnover	snapshot only																				3.950
Cash Velocity	snapshot only																				1.002
Capital Intensity	snapshot only																				1.469

Growth (YoY)

Metric	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Q3'26	Current
Revenue	35.6%	36.0%	23.2%	10.9%	-2.6%	-11.6%	-15.8%	-16.5%	-12.7%	-8.0%	-3.4%	2.7%	7.9%	10.5%	13.0%	10.3%	5.8%	4.5%	5.9%	7.9%	7.87%
Net Income	1.8%	95.1%	70.8%	42.5%	-19.1%	-19.7%	-31.3%	-35.1%	-24.6%	-22.3%	-11.4%	2.7%	17.2%	22.9%	26.9%	21.4%	1.3%	-0.8%	3.8%	2.8%	2.85%
EPS	1.7%	92.6%	69.9%	42.3%	-18.9%	-19.8%	-31.7%	-35.5%	-25.2%	-22.9%	-13.7%	-0.9%	12.7%	19.2%	25.2%	21.0%	1.4%	-1.1%	3.0%	1.8%	1.78%
FCF	1.8%	22.7%	-17.3%	-57.9%	-76.1%	16.4%	25.5%	72.7%	1.0%	-6.9%	-1.8%	-19.7%	-26.0%	-1.2%	-2.0%	-1.9%	-1.8%	49.8%	2.0%	1.4%	1.42%
EBITDA	1.4%	1.0%	73.2%	42.7%	-14.5%	-17.0%	-22.0%	-24.8%	-17.9%	-18.8%	-14.8%	-4.3%	4.0%	11.0%	16.1%	10.9%	-1.4%	-1.5%	6.0%	9.8%	9.84%
Op. Income	1.7%	1.2%	82.3%	48.7%	-17.1%	-19.1%	-27.2%	-30.6%	-23.8%	-23.8%	-17.0%	-6.9%	5.1%	11.2%	16.1%	15.7%	2.8%	3.3%	13.4%	11.5%	11.45%
OCF Growth	snapshot only																				1.48%
Asset Growth	snapshot only																				12.40%
Equity Growth	snapshot only																				7.10%
Debt Growth	snapshot only																				-4.20%
Shares Change	snapshot only																				1.05%
Dividend Growth	snapshot only																				4.79%

Growth (CAGR)

Metric	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Q3'26	Current
Revenue 3Y	14.5%	16.1%	15.7%	14.3%	10.9%	8.1%	7.2%	5.7%	4.9%	3.4%	0.1%	-1.7%	-2.8%	-3.5%	-2.8%	-1.8%	-0.1%	2.0%	5.0%	6.9%	6.93%
Revenue 5Y	10.7%	11.1%	10.8%	10.1%	8.3%	6.9%	5.8%	5.0%	5.0%	4.9%	4.7%	5.0%	5.2%	5.1%	6.1%	6.0%	5.7%	5.0%	3.7%	2.5%	2.51%
EPS 3Y	21.3%	18.5%	19.6%	17.3%	7.8%	9.6%	5.7%	3.2%	18.3%	6.0%	0.1%	-3.1%	-11.9%	-9.7%	-9.6%	-8.2%	-5.1%	-3.2%	3.6%	6.9%	6.86%
EPS 5Y	16.5%	14.6%	15.7%	14.7%	12.3%	10.2%	6.0%	3.0%	1.6%	0.5%	0.2%	0.6%	1.1%	3.9%	5.0%	5.7%	13.6%	7.0%	5.3%	2.3%	2.29%
Net Income 3Y	22.9%	19.8%	20.4%	18.0%	8.3%	10.2%	6.4%	3.8%	19.0%	6.8%	1.3%	-1.7%	-10.6%	-8.4%	-8.3%	-6.8%	-3.6%	-1.8%	5.3%	8.6%	8.62%
Net Income 5Y	17.9%	15.9%	16.8%	15.8%	13.2%	11.2%	6.9%	3.9%	2.5%	1.5%	1.2%	1.8%	2.4%	5.1%	6.2%	6.9%	14.9%	8.2%	6.5%	3.4%	3.45%
EBITDA 3Y	19.0%	18.7%	18.5%	17.0%	9.5%	10.2%	8.5%	5.9%	19.6%	11.1%	4.8%	0.9%	-10.0%	-9.2%	-8.3%	-7.2%	-5.6%	-3.9%	1.6%	5.2%	5.23%
EBITDA 5Y	13.9%	13.1%	12.6%	11.2%	7.8%	7.1%	5.3%	3.4%	3.4%	2.4%	2.0%	2.9%	2.3%	3.8%	4.8%	4.7%	11.9%	8.5%	7.2%	4.6%	4.58%
Gross Profit 3Y	14.5%	14.9%	15.2%	14.1%	8.2%	7.2%	6.1%	3.8%	15.1%	12.5%	7.5%	4.6%	-5.8%	-4.9%	-4.1%	-3.1%	5.6%	11.5%	20.6%	28.1%	28.12%
Gross Profit 5Y	9.8%	9.4%	9.5%	8.8%	5.8%	5.4%	4.0%	2.7%	3.1%	3.1%	2.9%	3.8%	3.6%	3.9%	5.0%	5.0%	15.4%	17.7%	18.9%	18.9%	18.94%
Op. Income 3Y	21.0%	21.3%	21.0%	19.0%	10.5%	11.1%	8.1%	4.2%	20.1%	10.5%	3.2%	-1.3%	-12.8%	-11.8%	-11.2%	-9.2%	-6.3%	-4.3%	3.0%	6.3%	6.28%
Op. Income 5Y	14.0%	12.7%	12.3%	10.8%	6.9%	6.1%	4.1%	2.5%	2.3%	1.9%	1.4%	1.8%	1.5%	3.0%	4.0%	4.0%	13.3%	9.1%	7.7%	4.4%	4.38%
FCF 3Y	51.5%	22.0%	-2.6%	-11.6%	-25.5%	-3.8%	-5.2%	-6.6%	9.9%	10.0%	0.6%	-16.4%	-29.3%	—	—	—	—	—	-0.8%	-31.9%	-31.93%
FCF 5Y	18.0%	3.2%	12.4%	3.8%	-1.2%	34.1%	7.4%	6.7%	10.7%	14.5%	2.6%	-0.8%	-9.3%	—	—	—	—	—	0.3%	-25.5%	-25.51%
OCF 3Y	49.6%	20.9%	-2.5%	-11.0%	-24.2%	-2.5%	-0.4%	3.4%	24.5%	22.8%	11.1%	-11.4%	-26.4%	—	—	—	—	—	-5.2%	-37.5%	-37.47%
OCF 5Y	16.1%	2.0%	10.7%	3.1%	-0.8%	32.9%	10.2%	13.0%	18.8%	21.6%	8.6%	2.4%	-7.3%	—	—	—	—	—	0.6%	-24.7%	-24.69%
Assets 3Y	0.8%	12.8%	12.6%	3.3%	18.7%	23.2%	19.3%	19.2%	28.3%	26.9%	24.8%	15.8%	18.1%	12.7%	9.2%	16.5%	10.6%	11.1%	13.0%	10.2%	10.16%
Assets 5Y	8.1%	12.8%	7.7%	3.6%	10.4%	7.8%	6.8%	6.7%	8.9%	10.9%	14.2%	9.6%	15.1%	20.1%	15.3%	15.1%	21.2%	20.7%	17.4%	14.0%	13.97%
Equity 3Y	4.7%	2.8%	4.1%	4.2%	16.5%	19.9%	18.3%	15.9%	29.8%	26.0%	27.0%	22.9%	26.1%	25.7%	22.2%	20.4%	18.5%	18.7%	18.6%	17.1%	17.15%
Book Value 3Y	3.3%	1.6%	3.4%	3.6%	16.0%	19.2%	17.5%	15.1%	29.1%	25.1%	25.5%	21.1%	24.2%	24.0%	20.4%	18.6%	16.7%	17.0%	16.8%	15.2%	15.25%
Dividend 3Y	5.0%	5.5%	6.3%	6.7%	-10.4%	-11.2%	-11.9%	-12.5%	1.0%	0.7%	0.4%	0.3%	0.4%	0.9%	0.7%	0.7%	0.6%	0.7%	0.8%	0.3%	0.27%

Growth Quality

Metric	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Q3'26	Current
Revenue Stability	0.74	0.74	0.81	0.85	0.79	0.70	0.65	0.57	0.49	0.40	0.31	0.28	0.25	0.19	0.25	0.33	0.55	0.76	0.70	0.40	0.398
Earnings Stability	0.38	0.54	0.66	0.77	0.44	0.56	0.45	0.35	0.13	0.15	0.09	0.08	0.06	0.09	0.06	0.06	0.04	0.01	0.01	0.00	0.001
Margin Stability	0.85	0.86	0.87	0.89	0.85	0.86	0.87	0.89	0.86	0.87	0.88	0.90	0.95	0.97	0.97	0.97	0.85	0.80	0.73	0.68	0.681
Rev. Growth Consistency	1.00	1.00	1.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	1.00	1.00	1.00	1.00	1.00	1.000
Earn. Growth Consistency	0.50	0.50	1.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	1.00	1.00	0.00	1.00	1.00	1.000
FCF Positive Streak	1	1	1	1	1	1	1	1	1	1	1	1	1	0	0	0	0	0	0	0	0
Earnings Persistence	0.50	0.50	0.50	0.83	0.92	0.92	0.87	0.86	0.90	0.91	0.95	0.99	0.93	0.91	0.89	0.91	0.99	1.00	0.98	0.99	0.989
Earnings Smoothness	0.06	0.36	0.48	0.65	0.79	0.78	0.63	0.57	0.72	0.75	0.88	0.97	0.84	0.79	0.76	0.81	0.99	0.99	0.96	0.97	0.972
ROE Trend	0.29	0.21	0.17	0.12	-0.13	-0.19	-0.23	-0.23	-0.33	-0.31	-0.29	-0.23	-0.13	-0.10	-0.04	-0.02	-0.04	-0.05	-0.01	-0.00	-0.000
Gross Margin Trend	0.09	0.07	0.06	0.05	0.03	0.06	0.05	0.03	-0.02	-0.03	-0.03	-0.02	-0.00	-0.00	0.00	0.01	0.09	0.18	0.28	0.36	0.357
FCF Margin Trend	0.14	-0.10	-0.13	-0.22	-0.21	0.05	0.04	0.03	-0.02	0.04	0.04	0.01	-0.01	-0.32	-0.46	-0.39	-0.32	-0.13	0.19	0.05	0.050
Sustainable Growth Rate	29.7%	23.3%	20.3%	13.9%	21.5%	18.8%	10.7%	6.0%	4.6%	3.9%	3.0%	4.2%	7.2%	8.0%	7.8%	7.5%	4.9%	4.9%	6.4%	6.4%	6.37%
Internal Growth Rate	17.9%	12.8%	11.9%	9.0%	12.3%	10.2%	6.0%	3.6%	2.4%	2.2%	1.8%	2.6%	4.3%	4.9%	5.3%	5.4%	3.1%	3.2%	4.5%	4.5%	4.45%

Cash Flow Quality

Metric	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Q3'26	Current
OCF/Net Income	1.15	0.62	0.50	0.37	0.36	0.93	1.03	1.30	1.33	1.50	1.33	0.89	0.64	-0.11	-0.72	-0.53	-0.43	-0.05	0.76	0.25	0.248
FCF/OCF	0.99	0.98	0.97	0.95	0.93	0.95	0.85	0.72	0.67	0.70	0.73	0.83	0.88	1.49	1.05	1.09	1.09	1.62	0.97	0.93	0.933
FCF/Net Income	snapshot only																				0.232
OCF/EBITDA	snapshot only																				0.178
CapEx/Revenue	0.5%	0.5%	0.5%	0.6%	0.7%	1.5%	4.4%	9.5%	11.5%	11.4%	9.1%	4.0%	2.2%	1.5%	1.1%	1.3%	1.1%	0.9%	0.6%	0.5%	0.46%
CapEx/Depreciation	snapshot only																				0.270
Accruals Ratio	-0.07	0.17	0.22	0.26	0.19	0.02	-0.01	-0.07	-0.06	-0.10	-0.06	0.02	0.07	0.23	0.36	0.33	0.25	0.19	0.05	0.15	0.149
Sloan Accruals	snapshot only																				-0.252
Cash Flow Adequacy	snapshot only																				0.310
Earnings Quality Score	snapshot only																				0.250

Dividends & Buybacks

Metric	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Q3'26	Current
Dividend Yield	3.7%	4.1%	5.7%	5.9%	3.7%	3.8%	4.2%	3.8%	3.2%	3.1%	3.3%	2.5%	2.6%	3.0%	3.2%	3.7%	3.9%	4.0%	3.4%	3.5%	3.72%
Dividend/Share	$2.99	$3.09	$3.21	$3.30	$2.18	$2.20	$2.22	$2.24	$2.26	$2.28	$2.27	$2.28	$2.31	$2.36	$2.40	$2.43	$2.46	$2.51	$2.56	$2.54	$2.63
Payout Ratio	69.8%	74.6%	75.1%	80.2%	62.8%	66.1%	76.2%	84.4%	87.1%	89.0%	90.4%	86.7%	78.8%	77.4%	76.1%	76.2%	82.8%	83.3%	78.8%	78.5%	78.50%
FCF Payout Ratio	61.4%	1.2%	1.6%	2.3%	1.9%	74.9%	87.0%	89.7%	97.8%	84.1%	93.1%	1.2%	1.4%	—	—	—	—	—	1.1%	3.4%	3.39%
Total Payout Ratio	80.5%	87.8%	88.0%	93.6%	78.4%	79.3%	91.3%	1.0%	1.0%	1.0%	1.1%	1.0%	92.7%	95.1%	93.5%	93.5%	1.0%	95.7%	90.1%	93.9%	93.89%
Div. Increase Streak	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	1	1	1	1	1	1
Chowder Number	0.24	0.26	0.28	0.29	-0.24	-0.25	-0.26	-0.28	0.08	0.08	0.08	0.08	0.09	0.10	0.10	0.10	0.10	0.11	0.11	0.09	0.094
Buyback Yield	0.6%	0.7%	1.0%	1.0%	0.9%	0.8%	0.8%	0.7%	0.6%	0.6%	0.6%	0.4%	0.5%	0.7%	0.7%	0.8%	0.9%	0.6%	0.5%	0.7%	0.68%
Net Buyback Yield	0.5%	0.7%	0.9%	0.9%	0.9%	0.7%	0.8%	0.7%	0.6%	0.5%	-1.4%	-1.0%	-1.0%	-1.0%	0.7%	0.8%	0.8%	0.6%	0.4%	0.6%	0.63%
Total Shareholder Return	4.2%	4.8%	6.6%	6.8%	4.6%	4.5%	4.9%	4.6%	3.8%	3.7%	1.9%	1.4%	1.5%	2.0%	4.0%	4.6%	4.8%	4.6%	3.8%	4.1%	4.11%

DuPont Factors

Metric	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Q3'26	Current
Tax Burden (NI/EBT)	0.75	0.73	0.84	0.87	0.87	0.88	0.74	0.75	0.72	0.71	0.72	0.65	0.72	0.72	0.70	0.75	0.75	0.75	0.74	0.74	0.742
Interest Burden (EBT/EBIT)	1.07	1.06	0.93	0.92	0.88	0.86	0.98	0.96	1.03	1.04	1.03	1.16	1.09	1.09	1.12	1.07	1.08	1.07	1.04	1.01	1.009
EBIT Margin	0.45	0.43	0.43	0.43	0.39	0.40	0.38	0.36	0.35	0.34	0.34	0.35	0.36	0.36	0.36	0.36	0.33	0.34	0.36	0.37	0.368
Asset Turnover	1.39	1.34	1.26	1.23	0.98	0.90	0.86	0.85	0.71	0.76	0.71	0.74	0.69	0.73	0.74	0.74	0.66	0.68	0.73	0.72	0.721
Equity Multiplier	1.96	2.06	1.90	1.68	1.97	2.04	1.87	1.73	1.96	1.82	1.73	1.63	1.73	1.71	1.55	1.47	1.60	1.58	1.48	1.49	1.494

Per Share

Metric	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Q3'26	Current
EPS (Diluted TTM)	$4.28	$4.15	$4.27	$4.12	$3.47	$3.33	$2.91	$2.65	$2.60	$2.56	$2.52	$2.63	$2.93	$3.05	$3.15	$3.18	$2.97	$3.02	$3.25	$3.24	$3.24
Book Value/Share	$5.16	$5.18	$5.88	$6.40	$6.84	$6.82	$7.14	$7.39	$7.67	$7.60	$9.12	$9.55	$9.90	$9.87	$10.27	$10.67	$10.88	$10.92	$11.36	$11.31	$11.31
Tangible Book/Share	$4.76	$4.78	$5.50	$6.03	$6.46	$6.43	$6.75	$7.01	$7.28	$7.22	$8.75	$9.17	$9.53	$9.50	$9.88	$10.28	$10.49	$10.53	$10.98	$10.93	$10.93
Revenue/Share	$11.82	$12.41	$12.51	$12.19	$11.54	$10.96	$10.47	$10.11	$10.00	$9.99	$9.86	$10.02	$10.38	$10.70	$10.99	$11.03	$11.00	$11.14	$11.55	$11.77	$11.90
FCF/Share	$4.86	$2.53	$2.05	$1.46	$1.16	$2.94	$2.55	$2.50	$2.31	$2.71	$2.44	$1.94	$1.64	$-0.50	$-2.38	$-1.82	$-1.38	$-0.25	$2.38	$0.75	$2.37
OCF/Share	$4.91	$2.59	$2.12	$1.53	$1.25	$3.10	$3.02	$3.45	$3.46	$3.85	$3.34	$2.34	$1.87	$-0.33	$-2.26	$-1.68	$-1.27	$-0.15	$2.45	$0.80	$2.44
Cash/Share	$4.21	$1.72	$4.18	$4.45	$5.33	$3.98	$4.16	$4.63	$5.34	$3.56	$5.25	$5.69	$5.99	$4.13	$4.47	$5.73	$2.82	$1.03	$11.80	$11.75	$11.75
EBITDA/Share	$5.64	$5.69	$5.69	$5.46	$4.83	$4.72	$4.41	$4.08	$3.93	$3.79	$3.67	$3.77	$3.93	$4.08	$4.20	$4.16	$3.88	$4.01	$4.41	$4.53	$4.53
Debt/Share	$0.50	$0.44	$0.38	$0.32	$2.81	$2.79	$2.34	$2.69	$2.82	$2.84	$2.79	$2.73	$2.73	$2.72	$2.75	$2.72	$2.68	$2.64	$2.59	$2.58	$2.58
Net Debt/Share	$-3.71	$-1.28	$-3.81	$-4.14	$-2.51	$-1.19	$-1.82	$-1.94	$-2.51	$-0.72	$-2.47	$-2.96	$-3.26	$-1.40	$-1.72	$-3.01	$-0.14	$1.61	$-9.21	$-9.17	$-9.17

Academic Models

Metric	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Q3'26	Current
Altman Z-Score	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	12.612
Altman Z-Prime	snapshot only																				21.484
Piotroski F-Score	8	4	7	6	4	4	4	4	5	4	5	5	7	5	4	4	4	4	4	5	5
Beneish M-Score	-3.16	-0.83	-1.56	-1.43	-1.84	-3.21	-2.86	-2.80	-2.66	-2.66	-2.55	-2.35	-2.05	-1.44	-0.67	-0.98	-1.17	-1.35	-1.85	-1.27	-1.266
Ohlson O-Score	snapshot only																				-9.274
ROIC (Greenblatt)	snapshot only																				92.05%
Net-Net WC	snapshot only																				$-1.19
EVA	snapshot only																				$142848380.61

Credit

Metric	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Q3'26	Current
Credit Rating	snapshot only																				AA
Credit Score	93.87	94.25	94.65	94.96	92.50	92.23	91.79	92.03	91.56	91.62	90.87	91.48	91.13	85.01	84.63	85.48	85.18	85.69	91.96	88.50	88.499
Credit Grade	snapshot only																				3
Credit Trend	snapshot only																				3.015
Implied Spread (bps)	snapshot only																				80.000
Industry Credit Rank	snapshot only																				72
Sector Credit Rank	snapshot only																				87

CNS NYSE

Edge Score

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Executive Compensation

C-Suite Compensation

CEO Pay Ratio

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet